<DOC>
	<DOC>NCT02464592</DOC>
	<brief_summary>The purpose of this study is to evaluate the diagnostic yield and safety of transbronchial lung biopsies (TBLB) with cryoprobe versus conventional forceps in patients with diffuse lung disease.</brief_summary>
	<brief_title>Diagnostic Yield and Safety of Transbronchial Lung Biopsy Using Cryoprobes Versus Conventional Forceps. A Multicenter Study</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases, Interstitial</mesh_term>
	<criteria>&gt;18 years old Patients with diffuse lung disease candidate to study with transbronchial lung biopsy (TBLB). Inform consent signed. FEV1 &lt;40% of reference value. Respiratory insufficiency (pO2 &lt;60 mmHg or pCO2 &gt;45 mmHg). Use of anticoagulant therapy or presence of a coagulation (disorder abnormal platelets counts, international normalized ratio &gt; 1.5). Bullous emphysema. Pulmonary arterial hypertension. Hypersensitivity to anaesthetic and sedative drugs (lidocaine, midazolam, propofol, remifentanyl). Psychiatric illness. Comorbidities that could increase the risk of the TBLB. Pregnancy.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>Cryoprobes</keyword>
	<keyword>Transbronchial lung biopsy</keyword>
	<keyword>Cryobiopsy</keyword>
</DOC>